Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 2.68 M2.47 M2.74 M2.57 M2.96 M2.71 M 10.98 M Research & development —————— — Operating income 56.75 M57.26 M60.18 M61.96 M61.55 M66.7 M 250.39 M Non-Operating Income, Total 2 000-3 00091 K296 K716 K-682 K 421 K Interest expense, net of interest capitalized 23.27 M24.1 M25.11 M28.82 M23.84 M26.39 M 104.15 M Non-Operating Income, excl. Interest Expenses -23.27 M-24.11 M-25.02 M-28.52 M-23.12 M-27.07 M -103.73 M Unusual income/expense —————— — Pretax income 23.78 M22.83 M25.75 M26.36 M24.72 M28.04 M 104.87 M Equity in earnings —————— — Taxes 5.37 M4.24 M4.99 M4.9 M4.92 M5.3 M 20.11 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 18.41 M18.59 M20.76 M21.45 M19.8 M22.74 M 84.76 M Discontinued operations —————— — Net income 18.41 M18.59 M20.76 M21.45 M19.8 M22.74 M 84.76 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 18.41 M18.59 M20.76 M21.45 M19.8 M22.74 M 84.76 M Basic earnings per share (Basic EPS) 1.551.571.751.811.671.91 7.14 Diluted earnings per share (Diluted EPS) 1.551.571.751.811.671.91 7.14 Average basic shares outstanding 11.84 M11.85 M11.85 M11.85 M11.88 M11.89 M — Diluted shares outstanding 11.84 M11.85 M11.85 M11.85 M11.88 M11.89 M — EBITDA 36.13 M36.59 M38.6 M43.37 M40.16 M44.81 M 166.96 M EBIT 35.08 M35.6 M37.66 M37.16 M39.37 M44.05 M 158.24 M Cost of revenue 1.95 M1.95 M1.95 M2.35 M2.55 M1.3 M 8.15 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 1.05 M984 K947 K6.22 M790 K763 K 8.72 M